CEFTIN از شرکت GLAXOSMITHKLINE

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CEFTIN از شرکت GLAXOSMITHKLINE

New Drug Application (NDA): 050605

Company: GLAXOSMITHKLINE

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CEFTIN CEFUROXIME AXETIL EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET;ORAL Discontinued

None

Yes No
CEFTIN CEFUROXIME AXETIL EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET;ORAL Discontinued

None

Yes No
CEFTIN CEFUROXIME AXETIL EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** TABLET;ORAL Discontinued

None

Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/28/1987 ORIG-1 Approval

Type 2 – New Active Ingredient

STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
03/05/2021 SUPPL-52 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050605s052,050672s038lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/050605Orig1s052; 050672Orig1s038ltr.pdf

04/25/2019 SUPPL-51 Labeling-Package Insert, Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050605s051,050672s037lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/50605Orig1s051; 50672Orig1s037ltr.pdf

10/13/2017 SUPPL-50 Labeling-Package Insert

Label (PDF)

Letter (PDF)

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050605s050,050672s036lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/050605Orig1s050,050672Orig1s36ltr.pdf

11/22/2016 SUPPL-49 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/050605s049,050672s035lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/050605Orig1s049,050672Orig1s035ltr.pdf

08/26/2015 SUPPL-48 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050605s048,050672s034lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/050605Orig1s048,050672Orig1s034ltr.pdf

06/26/2015 SUPPL-47 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050605s047,050672s033lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/050605Orig1s047,050672Orig1s033ltr.pdf

09/20/2014 SUPPL-46 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050605s043s046lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/050605Orig1s043,s046ltr.pdf

09/20/2014 SUPPL-43 Labeling-Package Insert, Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050605s043s046lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/050605Orig1s043,s046ltr.pdf

07/23/2007 SUPPL-42 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050605s042lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/050605s042ltr.pdf

06/03/2004 SUPPL-39 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50605slr039,50672slr025_ceftin_lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50605slr039,50672slr025ltr.pdf

07/24/2002 SUPPL-37 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/50605slr037ltr.pdf

12/20/2001 SUPPL-36 Manufacturing (CMC)

Label is not available on this site.

04/13/2001 SUPPL-35 Manufacturing (CMC)-Control

Label is not available on this site.

07/03/2001 SUPPL-34 Manufacturing (CMC)

Label is not available on this site.

04/11/2002 SUPPL-33 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/50605s33lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/50605s33ltr.pdf

08/24/1999 SUPPL-32 Efficacy-Labeling Change With Clinical Data

Letter (PDF)

Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/50605ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50605S032_Ceftin.pdf

03/29/2002 SUPPL-31 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/50605s31lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/50605s31ltr.pdf

03/24/1998 SUPPL-30 Labeling

Label is not available on this site.

01/16/1998 SUPPL-29 Manufacturing (CMC)

Label is not available on this site.

11/19/1997 SUPPL-28 Manufacturing (CMC)

Label is not available on this site.

06/04/1997 SUPPL-27 Labeling

Label is not available on this site.

12/23/1996 SUPPL-26 Labeling

Label is not available on this site.

09/17/1997 SUPPL-25 Efficacy-New Dosing Regimen

Label is not available on this site.

12/06/1996 SUPPL-24 Efficacy-New Indication

Label is not available on this site.

09/13/1996 SUPPL-23 Labeling

Label is not available on this site.

09/13/1996 SUPPL-22 Labeling

Label is not available on this site.

12/23/1996 SUPPL-21 Labeling

Label is not available on this site.

08/30/1995 SUPPL-20 Manufacturing (CMC)

Label is not available on this site.

06/30/1994 SUPPL-19 Labeling

Label is not available on this site.

12/19/1996 SUPPL-17 Efficacy-New Indication

Label is not available on this site.

06/28/1993 SUPPL-16 Manufacturing (CMC)-Control

Label is not available on this site.

10/18/1993 SUPPL-15 Labeling

Label is not available on this site.

01/31/1992 SUPPL-14 Manufacturing (CMC)

Label is not available on this site.

01/27/1993 SUPPL-13 Labeling

Label is not available on this site.

08/09/1991 SUPPL-12 Manufacturing (CMC)

Label is not available on this site.

01/27/1993 SUPPL-11 Labeling

Label is not available on this site.

08/19/1991 SUPPL-9 Labeling

Label is not available on this site.

01/31/1992 SUPPL-8 Efficacy-New Indication

Label is not available on this site.

03/13/1996 SUPPL-7 Efficacy-New Indication

Label is not available on this site.

08/19/1991 SUPPL-6 Labeling

Label is not available on this site.

08/19/1991 SUPPL-5 Labeling

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
03/05/2021 SUPPL-52

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050605s052,050672s038lbl.pdf
04/25/2019 SUPPL-51

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050605s051,050672s037lbl.pdf
04/25/2019 SUPPL-51

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050605s051,050672s037lbl.pdf
10/13/2017 SUPPL-50

Labeling-Package Insert

Label (PDF)

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050605s050,050672s036lbl.pdf
11/22/2016 SUPPL-49

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/050605s049,050672s035lbl.pdf
08/26/2015 SUPPL-48

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050605s048,050672s034lbl.pdf
06/26/2015 SUPPL-47

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050605s047,050672s033lbl.pdf
09/20/2014 SUPPL-46

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050605s043s046lbl.pdf
09/20/2014 SUPPL-43

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050605s043s046lbl.pdf
09/20/2014 SUPPL-43

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050605s043s046lbl.pdf
07/23/2007 SUPPL-42

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050605s042lbl.pdf
06/03/2004 SUPPL-39

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50605slr039,50672slr025_ceftin_lbl.pdf
04/11/2002 SUPPL-33

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/50605s33lbl.pdf
03/29/2002 SUPPL-31

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/50605s31lbl.pdf
بخوانید  CEFTIN از شرکت GLAXOSMITHKLINE
به بالای صفحه بردن